Matrix metalloproteinases: multifunctional contributors to tumor progression.

By L. Mccawley, L. Matrisian. Molecular medicine today, 2000

666 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology and Allergy, Oncology

View Paper: https://www.semanticscholar.org/paper/86fd62ae62d507cea8af5a1df0d141f287f349f7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. D. Edwards

In Oncology

1. D. Edwards

Citations in the corpus

• Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. (2001, neutral): “Cervix Carcinoma (Ca) 77 (99) 24 (33) 68 0 8/24 Squamous cell Ca 54 (100) 14 (25) 74 0 4/14 Adenocarcinoma 15 (93) 8 (50) 80 0 4/8 Cervical intraepithelial Neoplasia (CIN I–III) 129 (91) 6 (50) 80 0 3/6 Adenocarcinoma in-situ 20 (100) 4 (75) 90 0 3/4 Uterine corpus Endometrial Ca 27 (89) 12 (67) 30 ”
• Metalloproteinases in biology and pathology of the nervous system (2001, background): “More recent studies have extended the roles of MMPs to other features of tumour progression, notably proliferation, angiogenesis and survival 49 .”
• IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 (2003, background): “Degradation of the extracellular matrix by MMPs is required in endothelial cell migration, organization, and, hence, angiogenesis (17, 18).”